Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 57,007,759
- Total 13F value
- $1,734,195,451
- Share change
- +7,800,920
- Put/Call ratio
- 320%
- SEC-reported price per share
- $30.42
- Number of holders
- 149
- Value change
- +$237,069,658
- Number of buys
- 90
- Number of sells
- 55
- Shares outstanding
- 92,799,600
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q2 2022
Institutions
149
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 5.4%
Showing 1-6 of 15 holder rows.
Quick read
Avoro Capital Advisors LLC leads the comparable SEC ownership view at 5.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Avoro Capital Advisors LLC
5.4%
FMR LLC
4.1%
DRIEHAUS CAPITAL MANAGEMENT LLC
3.6%
PERCEPTIVE ADVISORS LLC
2.6%
Capital World Investors
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
Company
|
5.4%
|
$152,391,000
4,985,000 shares
|
— | 31 Mar 2022 |
| FMR LLC |
13F
Company
|
4.1%
|
$117,190,000
3,833,476 shares
|
— | 31 Mar 2022 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
3.6%
|
$100,894,000
3,300,427 shares
|
— | 31 Mar 2022 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2.6%
|
$73,718,000
2,411,447 shares
|
— | 31 Mar 2022 |
| Capital World Investors |
13F
Company
|
2.5%
|
$69,546,000
2,274,974 shares
|
— | 31 Mar 2022 |
| Polar Capital Holdings Plc |
13F
Company
|
2.4%
|
$66,950,000
2,190,059 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
149
Shares
57,007,759
Rows available
149
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
128
Q2 2022 holders
149
Holder diff
21
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend